Update on tolterodine extended-release or treatment of overactive bladder

Tola Omotosho, Chi Chiung Grace Chen

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Overactive bladder is a prevalent condition which negatively impacts quality of life and puts a significant economical burden on society. First-line therapy often includes pharmacotherapy with antimuscarinic medications, and numerous research studies have demonstrated that tolterodine extended-release (ER) is an efficacious and tolerable formulation of this class of medication. This review provides an update on the clinical use of tolterodine ER, detailing the current literature on its efficacy, tolerability, adverse effects, and comparability with other commonly prescribed medications for the treatment of overactive bladder.

Original languageEnglish (US)
Pages (from-to)185-191
Number of pages7
JournalOpen Access Journal of Urology
Volume2
Issue number1
DOIs
StatePublished - 2010

Keywords

  • Antimuscarinics
  • Efficacy
  • Overactive bladder
  • Quality of life
  • Tolterodine
  • Urge urinary incontinence
  • Urgency

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Update on tolterodine extended-release or treatment of overactive bladder'. Together they form a unique fingerprint.

Cite this